Clinical Trials Logo

Clinical Trial Summary

This study investigates the presence of a possible link between treatment with danazol and expression of endometrial αvβ3 integrin which might allow tailoring of danazol treatment to the subset of repeated IVF/ET failure that might benefit most from it.

38 eligible ovulatory women were recruited aged 20 - 38 years with unexplained recurrent implantation failure (RIF). Timed suction endometrial biopsy was obtained from participants during the implantation window of the pretreatment cycle, followed by immunohistochemical staining for endometrial αvβ3 integrin expression, scored using H-score.

Participants were treated with danazol (Danol® 200mg capsules, Sanofi, Guildford, UK) in daily dosage of 400 mg for 12 weeks. Post-treatment suction endometrial biopsy was obtained during the implantation window following the first ovulation after danazol treatment and endometrial αvβ3 integrin expression was compared to the pretreatment cycle.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03563664
Study type Interventional
Source Ain Shams University
Contact
Status Completed
Phase Phase 3
Start date August 1, 2015
Completion date August 15, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04169451 - IUI With Letrozole Versus in Natural Cycle N/A
Completed NCT01672801 - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT N/A
Completed NCT01232465 - Impact of Sperm DNA Integrity on In Vitro Cycles N/A
Not yet recruiting NCT01237535 - Luteal Phase Support With Progesterone Versus Estrogen and Progesterone on Pregnancy Rates Phase 4
Completed NCT02272439 - Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan N/A
Terminated NCT00650754 - Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility Phase 2/Phase 3
Recruiting NCT04754243 - New Protocol in Unexplained Infertility Phase 4
Completed NCT03018314 - Serum Kisspeptin Levels in Infertile Women N/A
Completed NCT02488434 - The Effects of Using Fertile Chip in Sperm Selection for Intracytoplasmic Sperm Injection in Unexplained Infertility Phase 3
Completed NCT02739516 - Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility Phase 3
Completed NCT02628756 - Endometrial Injury in Women With Unexplained Infertility N/A
Completed NCT01044862 - Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation Phase 3
Recruiting NCT03386552 - A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility Phase 2
Completed NCT04465045 - Unexplained Infertility Treated by Hysteroscopy-laparoscopy
Completed NCT03461601 - Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility N/A
Completed NCT01859520 - Swim up and Gradient Methods Used in Assisted Reproduction Techniques on DNA Fragmentation of Spermatozoa N/A
Active, not recruiting NCT03828786 - Uterine Scratching in Intra-Uterine Insemination N/A
Completed NCT03397693 - Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
Withdrawn NCT04955574 - Probiotic and Antibiotic Therapies in Women With Unexplained Infertility Phase 2
Not yet recruiting NCT03398993 - Effect of Endometrial Injury in Couples With Unexplained Infertility N/A